Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
When index levels fall, use a calm, systematic approach to reassess risk, rebalance as needed, and protect capital. This intro covers the core steps you can take now.
13,497 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A 28-year-old with $730,000 zero debt asks Dave Ramsey for guidance on next steps, sparking a broader look at how you...
Software shares have slid toward what some call bargain territory, but a growing argument centers on whether hidden c...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
New market dynamics in 2026 are quietly reshaping retirement portfolios: two growth-focused ETFs, little known to man...
Positive policy shifts are starting to shape how retirees plan their finances. This article breaks down the latest fe...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Over the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...
Goldman Sachs' latest research paints a paradox: trillions are pouring into AI infrastructure, but returns remain mur...
Treasury yields climbed past 4.6% as inflation signals remained stubborn. Here’s how JBND could respond and what inve...
Investors are weighing Plug Power's turnaround against hydrogen hype. This guide breaks down the signals, risks, and ...
SPY and VOO track the same S&P 500 index, but SPY’s older UIT structure carries a higher fee that compounds over time...